Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
29.81
+0.93 (3.22%)
Nov 22, 2024, 4:00 PM EST - Market closed
Castle Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | 6.08 | -57.47 | -67.14 | -31.29 | -10.28 | 5.28 | Upgrade
|
| Depreciation & Amortization | 13.45 | 12.33 | 10.54 | 3.41 | 0.47 | 0.36 | Upgrade
|
| Other Amortization | - | - | - | - | 0.84 | 1.93 | Upgrade
|
| Loss (Gain) From Sale of Investments | -6.71 | -5.49 | -1.37 | - | - | - | Upgrade
|
| Stock-Based Compensation | 50.68 | 51.22 | 36.32 | 21.74 | 8.31 | 1.25 | Upgrade
|
| Other Operating Activities | 4.03 | 0.41 | -20.01 | -8.74 | 1.38 | -1.84 | Upgrade
|
| Change in Accounts Receivable | -13.03 | -14.93 | -6.22 | -4.63 | 1.66 | -0.9 | Upgrade
|
| Change in Inventory | -0.8 | -3.96 | -1.68 | 0.33 | -0.98 | -0.36 | Upgrade
|
| Change in Accounts Payable | -0.79 | 5.71 | 0.58 | -0.18 | 0.17 | 0.56 | Upgrade
|
| Change in Other Net Operating Assets | 6.17 | 6.56 | 7.31 | 0.38 | 8.3 | 0.74 | Upgrade
|
| Operating Cash Flow | 59.09 | -5.63 | -41.66 | -18.98 | 9.87 | 7.02 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | 40.63% | - | Upgrade
|
| Capital Expenditures | -24.55 | -13.62 | -5.63 | -3.48 | -4.75 | -0.94 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | 0.01 | 0.2 | 0.01 | 0 | - | Upgrade
|
| Cash Acquisitions | - | - | -26.42 | -63.18 | - | - | Upgrade
|
| Investment in Securities | -39.04 | -2.58 | -134.69 | - | - | - | Upgrade
|
| Investing Cash Flow | -63.58 | -16.18 | -166.55 | -66.66 | -4.75 | -0.94 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 20.93 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 1.78 | Upgrade
|
| Total Debt Issued | 10 | - | - | - | - | 22.71 | Upgrade
|
| Long-Term Debt Repaid | - | -0.14 | -0.12 | -0.01 | -27.36 | -1.79 | Upgrade
|
| Total Debt Repaid | -0.11 | -0.14 | -0.12 | -0.01 | -27.36 | -1.79 | Upgrade
|
| Net Debt Issued (Repaid) | 9.89 | -0.14 | -0.12 | -0.01 | -27.36 | 20.92 | Upgrade
|
| Issuance of Common Stock | 4.73 | 2.98 | 3.33 | 6.55 | 333.25 | 67.32 | Upgrade
|
| Repurchase of Common Stock | -6.4 | -5.13 | -1.69 | -0.78 | - | - | Upgrade
|
| Other Financing Activities | - | - | - | -0.34 | - | - | Upgrade
|
| Financing Cash Flow | 8.23 | -2.3 | 1.52 | 5.42 | 305.89 | 88.29 | Upgrade
|
| Net Cash Flow | 3.74 | -24.11 | -206.69 | -80.22 | 311.01 | 94.37 | Upgrade
|
| Free Cash Flow | 34.54 | -19.25 | -47.29 | -22.47 | 5.11 | 6.08 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | -15.86% | - | Upgrade
|
| Free Cash Flow Margin | 11.07% | -8.76% | -34.51% | -23.88% | 8.16% | 11.72% | Upgrade
|
| Free Cash Flow Per Share | 1.22 | -0.72 | -1.81 | -0.89 | 0.27 | 0.70 | Upgrade
|
| Cash Interest Paid | 0.01 | 0.01 | 0.02 | 0 | 1.98 | 2.21 | Upgrade
|
| Cash Income Tax Paid | 0.2 | 0.2 | 0.12 | 0.02 | 0.1 | -0.15 | Upgrade
|
| Levered Free Cash Flow | 30.83 | 0.82 | -14.69 | -5.03 | 7.47 | 2.85 | Upgrade
|
| Unlevered Free Cash Flow | 31.13 | 0.83 | -14.68 | -5.03 | 8.28 | 3.78 | Upgrade
|
| Change in Net Working Capital | 7.8 | 6.62 | -1.05 | 1.64 | -9.51 | 1.47 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.